Study of participation patterns in advanced melanoma patients
Part of Cancer, Skin clinical trials.
This study looks at how people with stage IV melanoma take part in research. It helps doctors understand what works best for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with stage IV melanoma.
- You can understand the study and agree to take part.
- You are not pregnant or nursing.
- You do not have serious mental health or substance use issues that would make it hard to follow the study.
- You can use a computer or smartphone to report information regularly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with advanced melanoma (a serious skin cancer) feel during treatment with immunotherapy. It aims to better understand the symptoms they experience, so doctors can help manage them.
This study looks at patterns of participation among people with metastatic prostate cancer. It aims to understand how patients engage with their care and research, which could help improve future trial designs.
This study looks at immune cells in your blood to find patterns that might show how well a treatment called anti-PD1 immunotherapy works for melanoma. Your participation could help doctors better understand who benefits from this therapy.
This study follows adults with certain melanoma stages to better understand the disease over time. You may be asked to share tissue samples (if available) so researchers can study tumor biology and track outcomes.
This study looks at immune and tumor “behavior” markers in people with metastatic melanoma after standard treatment. It may help researchers understand why treatment works for some people and not others by testing blood and skin tumor samples.
This study looks at serial (repeated) tumour biopsies and blood samples in people with advanced melanoma. The goal is to understand biomarkers and disease changes over time, which may help improve future treatment decisions.
Hear when a new Stage IV Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.